Skip to Content

How does Besponsa work to treat acute lymphoblastic leukemia (ALL)?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017
Besponsa (inotuzumab ozogamicin), from Pfizer, is a CD22 monoclonal antibody and calicheamicin cytotoxic agent conjugate for relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) in adults. Besponsa works by binding to B-cell ALL cancer cells that express the CD22 antigen and blocks the growth of cancerous cells.
Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What is the difference between Fiasp and NovoLog?

Posted 7 Nov 2017 1 answerFAQ by Drugs.com

How is Zilretta administered?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com

What is the cost of Yescarta?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com

How is Yescarta administered?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com

What is the difference between Zostavax and Shingrix?

Posted 8 Nov 2017 1 answerFAQ by Drugs.com